Anthony Cooper
Principal investigator, leads Javelin Oncology, Inc..
BiotechFounder
Built from public records only: federal awards, patents, filings and papers.Is this you? Contact Noair Lab to claim this profile, correct it or hide it.
2019First federal award
$917KFederal grants as PI3 awards
0Patents grantedNone matched
0PapersOpenAlex
Federal awards and patents by year
AwardsPatents
3 awards · $917K
| Date | Agency | Award | Amount | Company |
|---|---|---|---|---|
| Jun 15, 2022 | NIH | SBIR Phase I Chimeric Switch Receptors to Potentiate CAR T Cell Therapy for Solid Tumor Cancers | $329K | Javelin Oncology, Inc. |
| May 10, 2019 | NIH | SBIR Phase I A Novel Target for CAR T Cell Therapy Using Precision Oncology Approaches | $294K | Javelin Oncology, Inc. |
| May 10, 2019 | NIH | SBIR Phase I A Novel Target for CAR T Cell Therapy Using Precision Oncology Approaches | $294K | Javelin Oncology, Inc. |
1 patents as inventor
Matched by the first inventor’s name and the patent’s company.
Peer ranks
Federal funding#1,854
Awards as PI#822
Patents#273
Companies
- Javelin Oncology, Inc.Leads (SEC Form D) · Biotech
Federal awards through Oct 21, 2026 and patents through Oct 20, 2026. Awards come from NIH, NSF and other agency records that name a principal investigator; DoD and NASA contract awards do not, so they are not shown here. Researchers are matched by name and company.